Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
In Reply Dr Fujita questions our conclusion that follow-up strategies should not be stage-specific based on 2 previous studies: (1) the results of a trial of follow-up strategies1 that reported a differential effect by stage and (2) a report2 that only 8% of patients undergoing curative resection of metastases originally present with stage I tumors.
Primrose JN, Mant D. Surveillance for Recurrence of Colorectal Cancer—Reply. JAMA. 2014;311(20):2128. doi:10.1001/jama.2014.3417